Dela Cerna, Rovelito .
HRN: 25-62-78 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/04/2024
CEFUROXIME 750MG (VIAL)
08/04/2024
08/11/2024
IV
750mg
Q8 X7days
TBI Mild Sec To MVA
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes